Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

Detalles Bibliográficos
Autores principales: Ordoñez-Boschetti, Laura, Rey, Roberto, Cruz, Ana, Sinha, Arijit, Reynolds, Tracy, Frider, Nadina, Alvarenga, Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522032/
https://www.ncbi.nlm.nih.gov/pubmed/26216785
http://dx.doi.org/10.1007/s12325-015-0230-4
_version_ 1782383901319102464
author Ordoñez-Boschetti, Laura
Rey, Roberto
Cruz, Ana
Sinha, Arijit
Reynolds, Tracy
Frider, Nadina
Alvarenga, Regina
author_facet Ordoñez-Boschetti, Laura
Rey, Roberto
Cruz, Ana
Sinha, Arijit
Reynolds, Tracy
Frider, Nadina
Alvarenga, Regina
author_sort Ordoñez-Boschetti, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-4522032
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-45220322015-08-03 Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study Ordoñez-Boschetti, Laura Rey, Roberto Cruz, Ana Sinha, Arijit Reynolds, Tracy Frider, Nadina Alvarenga, Regina Adv Ther Erratum Springer Healthcare 2015-07-28 2015 /pmc/articles/PMC4522032/ /pubmed/26216785 http://dx.doi.org/10.1007/s12325-015-0230-4 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Erratum
Ordoñez-Boschetti, Laura
Rey, Roberto
Cruz, Ana
Sinha, Arijit
Reynolds, Tracy
Frider, Nadina
Alvarenga, Regina
Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
title Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
title_full Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
title_fullStr Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
title_full_unstemmed Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
title_short Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
title_sort erratum to: safety and tolerability of fingolimod in latin american patients with relapsing-remitting multiple sclerosis: the open-label first latam study
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522032/
https://www.ncbi.nlm.nih.gov/pubmed/26216785
http://dx.doi.org/10.1007/s12325-015-0230-4
work_keys_str_mv AT ordonezboschettilaura erratumtosafetyandtolerabilityoffingolimodinlatinamericanpatientswithrelapsingremittingmultiplesclerosistheopenlabelfirstlatamstudy
AT reyroberto erratumtosafetyandtolerabilityoffingolimodinlatinamericanpatientswithrelapsingremittingmultiplesclerosistheopenlabelfirstlatamstudy
AT cruzana erratumtosafetyandtolerabilityoffingolimodinlatinamericanpatientswithrelapsingremittingmultiplesclerosistheopenlabelfirstlatamstudy
AT sinhaarijit erratumtosafetyandtolerabilityoffingolimodinlatinamericanpatientswithrelapsingremittingmultiplesclerosistheopenlabelfirstlatamstudy
AT reynoldstracy erratumtosafetyandtolerabilityoffingolimodinlatinamericanpatientswithrelapsingremittingmultiplesclerosistheopenlabelfirstlatamstudy
AT fridernadina erratumtosafetyandtolerabilityoffingolimodinlatinamericanpatientswithrelapsingremittingmultiplesclerosistheopenlabelfirstlatamstudy
AT alvarengaregina erratumtosafetyandtolerabilityoffingolimodinlatinamericanpatientswithrelapsingremittingmultiplesclerosistheopenlabelfirstlatamstudy

Ejemplares similares